Replay available

Virios Therapeutics, Inc. (VIRI) Q3 2023 Earnings Call

Virios Therapeutics, Inc. (NASDAQ: VIRI) Q3 2023 earnings conference call, held 2023-11-13. Replay captured from the company's public earnings webcast.

Mon, November 13, 2023 at 8:30 AMendedReplay
Virios Therapeutics, Inc. (VIRI) Q3 2023 Earnings Call

Hosted by

Featured presenters

Angela Walsh

Senior Vice President of Finance and Treasurer

Greg Duncan

Chief Executive Officer

Sean Lee

Analyst at HC Wainwright

David Bouts

Analyst at Zacks Small Cap Research

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dogwood Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:02.230 Good day and welcome to the Verios Therapeutics, Inc. 00:00:02.230 -- 00:00:04.050 Third Quarter 2023 00:00:04.050 -- 00:00:09.971 Earnings Update. At this time, all participants have been placed on a listen-only mode. 00:00:09.971 -- 00:00:14.453 Please be advised that today's call is being recorded at the company's request. 00:00:14.453 -- 00:00:18.434 At this time, I'd like to turn the call over to Angela Walsh, Senior Vice President of 00:00:18.434 -- 00:00:21.094 Finance and Treasurer for Verios Therapeutics. 00:00:21.094 -- 00:00:23.694 Please proceed, Angela. 00:00:23.955 -- 00:00:27.976 Thank you. Good morning, everyone, and thank you for joining us on today's conference 00:00:27.976 -- 00:00:32.848 call. We are pleased to be with you today to discuss various therapeutics third quarter 00:00:32.848 -- 00:00:36.330 financial results and to give you a corporate update. 00:00:36.330 -- 00:00:41.814 Please note that our financial results press release is now available on our website. 00:00:41.814 -- 00:00:46.238 Before we begin, I'd like to remind everyone that statements made during this conference 00:00:46.238 -- 00:00:51.061 call will include four looking statements within the meaning of the Private Securities 00:00:51.061 -- 00:00:54.652 Litigation Reform Act of 1995. 00:00:54.704 -- 00:00:59.547 which involve risks and uncertainties that can cause actual results to differ materially 00:00:59.547 -- 00:01:04.270 from the information expressed or implied by these four LICN statements. 00:01:04.270 -- 00:01:08.433 For more information regarding such risks and uncertainties, 00:01:08.433 -- 00:01:13.677 please see the risk factors outlined in the company's filings with the SEC. 00:01:13.677 -- 00:01:18.380 Any four LICN statem...